Commentary: Neoadjuvant checkpoint inhibitors in resectable non–small cell lung cancer—Ready for prime time?

Boris Sepesi, Tina Cascone

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Commentary: Neoadjuvant checkpoint inhibitors in resectable non–small cell lung cancer—Ready for prime time?'. Together they form a unique fingerprint.